No abstract available
MeSH terms
-
Cardiovascular Agents / therapeutic use*
-
Drug Approval / legislation & jurisprudence*
-
Europe
-
Evidence-Based Medicine / legislation & jurisprudence*
-
Government Regulation*
-
Healthcare Disparities / legislation & jurisprudence*
-
Heart Failure / diagnosis
-
Heart Failure / drug therapy*
-
Heart Failure / physiopathology
-
Humans
-
Ivabradine / adverse effects
-
Ivabradine / therapeutic use*
-
Patient Safety
-
Policy Making
-
Risk Assessment
-
Risk Factors
-
United States
-
United States Food and Drug Administration / legislation & jurisprudence*
Substances
-
Cardiovascular Agents
-
Ivabradine